Details for 2019734289

Up to date per 03.04.2026

Actions

Title / Product Name

PURINONEDERIVATE UND IHRE VERWENDUNG ZUR BEHANDLUNG VON KREBS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2019734289

EP Publication Number

3807278

E-Number

1515235

Language

PCT Number

EP19065686

Publication Date

21.04.2021 A

31.08.2022 B1

Registration Date

31.08.2022

AT Publication Date

15.09.2022

Application Date

14.06.2019

Registration Number

Priorities

15.06.2018

201862685325 P

IPC

C07D 473/32 20060101AFI20191220BHEP

Maximum Duration of Protection

14.06.2039

Owner

Astrazeneca AB 151 85 SödertäljeSE

CANCER RESEARCH TECHNOLOGY LIMITEDAngel Building 407 St. John Street London EC1V 4ADGB

Representative

No representatives present

Inventor

FINLAY, Maurice, Raymond, VerschoyleAstraZeneca UK Limited 1 Francis Crick Avenue, Cambridge Biomedical Campus Cambridge Cambridgeshire CB2 0AAGB

GOLDBERG, Frederick, WoolfAstraZeneca UK Limited 1 Francis Crick Avenue, Cambridge Biomedical Campus Cambridge Cambridgeshire CB2 0AAGB

HOWARD, Martin, RichardAstraZeneca UK Limited 1 Francis Crick Avenue, Cambridge Biomedical Campus Cambridge Cambridgeshire CB2 0AAGB

TING, Attilla, Kuan, TsueiAstraZeneca UK Limited 1 Francis Crick Avenue, Cambridge Biomedical Campus Cambridge Cambridgeshire CB2 0AAGB